Surmodics, Inc. engages in the provision of surface modification technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. The firm operates through the following segments: Medical Device, In Vitro Diagnostics, and Corporate. The Medical Device segment designs, develops, and manufactures vascular interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment is composed of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
389
Frequently Asked Questions
What is Market Cap of Surmodics, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Surmodics, Inc. market cap is $456.95M.
What is the 52-week high for Surmodics, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Surmodics, Inc. 52 week high is $40.39 as of September 15, 2025.
What is the 52-week low for Surmodics, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Surmodics, Inc. 52 week low is $26.00 as of September 15, 2025.
What is Surmodics, Inc. stock price today?
Surmodics, Inc. stock price today is $31.96.
What was Surmodics, Inc. stock price yesterday?
Surmodics, Inc. stock price yesterday was $32.27.
What is the PE ratio of Surmodics, Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Surmodics, Inc.’s P/E ratio is -25.84.
What is the Price-to-Book ratio of Surmodics, Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Surmodics, Inc. P/B ratio is 4.1054.
What is the 50-day moving average of Surmodics, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Surmodics, Inc. 50-day moving average is $34.06.